Cargando…
A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats
Osteoporosis is a bone disease that has no definite cure. Current treatments for osteoporosis are divided into two categories: anti-resorptive and anabolic. However, these treatments are not perfect and have considerable risks. In addition, bone quality often declines over time with these treatments...
Autores principales: | Sequeira, Linda, Nguyen, John, Wang, Liyun, Nohe, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402306/ https://www.ncbi.nlm.nih.gov/pubmed/32664215 http://dx.doi.org/10.3390/ijms21144874 |
Ejemplares similares
-
Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice
por: Nguyen, John, et al.
Publicado: (2018) -
Mechanisms of Cellular Internalization of Quantum Dot® Conjugated Bone Formation Mimetic Peptide CK2.3
por: Vrathasha, Vrathasha, et al.
Publicado: (2018) -
Plum and
Soy Aglycon Extracts Superior at Increasing
Bone Calcium Retention in Ovariectomized Sprague Dawley Rats
por: Pawlowski, Jessica W., et al.
Publicado: (2014) -
Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis
por: Vrathasha, Vrathasha, et al.
Publicado: (2019) -
A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway
por: Nguyen, John, et al.
Publicado: (2020)